Sabby Management’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History
Bought
Maintained
Sold
Other funds holding MTRI
SFCM
Sabby Management's MTRI Position: Q3 2026 in Review
Sabby Management sold out of Mentari Therapeutics, Inc. Common Stock (MTRI) in Q3 2026, closing a stake of 4,497 shares — an estimated $69.7K sold.
Sabby Management first reported a position in MTRI in Q3 2022 and held it in 8 quarters. The position peaked at $482K in Q3 2025. 16 funds tracked by Wall St. Rank hold MTRI as of Q3 2026.
- Sabby Management reported no remaining Mentari Therapeutics, Inc. Common Stock position as of Q3 2026 after selling out during the quarter.
- Sabby Management sold 4,497 Mentari Therapeutics, Inc. Common Stock shares in Q3 2026, an estimated $69.7K.
- Sabby Management first reported a position in Mentari Therapeutics, Inc. Common Stock in Q3 2022 and held it in 8 quarters.
- Sabby Management's Mentari Therapeutics, Inc. Common Stock position peaked at $482K in Q3 2025.
- 16 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q3 2026.
Based on Sabby Management's 13F filing for Q3 2026, filed 13 Nov 2026.